110 likes | 234 Views
Active (E2F). Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1). Strategies for signalling inhibition. Immune effector cell. Anti-ligand mAbs. Bispecific Abs. scFv/toxin conjugates. Ligand/toxin conjugate. Ligand- genistein conjugates. Anti-receptor mAbs.
E N D
Active (E2F) Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)
Strategies for signalling inhibition Immuneeffector cell Anti-ligand mAbs BispecificAbs scFv/toxinconjugates Ligand/toxin conjugate Ligand- genisteinconjugates Anti-receptormAbs Inhibitors of other signalling molecules Nucleus IntracellularscFvs Tyrosine kinase inhibitors (TKIs) Antisense
Mode of action of EGFR inhibitors EGF/TGFα R R Antibody Extracellular Membrane û û Intracellular EGFR-TKI EGFR-TKI K K û Cell survival (anti-apoptosis) Proliferation Signalling DNA Growth factors Angiogenesis Chemotherapy/ radiotherapy sensitivity Metastasis R, epidermal growth factor receptor